TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.

Suzanne Shusterman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.